Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis

References

• Vogenberg FR, Isaacson BC, Pursel M. Personalized medicine. Pharm Ther. 2010;35(10):560–576.
   Google Scholar
• Moaddeb J, Haga SB. Pharmacogenetic testing: current evidence of clinical utility. Ther Adv Drug Saf. 2013;4(4):155–169.
   PubMedGoogle Scholar
• Wang L, Pelleymounter L, Weinshilboum R, et al. Very important pharmacogene summary: thiopurine S-methyltransferase. Pharmacogenet Genomics. 2010;20(6):401–405. .
   PubMed Web of Science ®Google Scholar
• Dean L, Kane M. Mercaptopurine therapy and TPMT and NUDT15 genotype. Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US); (2012).
   Google Scholar
• Azimi F, Jafariyan M, Khatami S, et al. Assessment of thiopurine–based drugs according to thiopurine S-methyltransferase genotype in patients with acute lymphoblastic leukemia. Iran J Pediatr Hematol Oncol. 2014;4(1):32–38.
   PubMedGoogle Scholar
• Relling MV, Schwab M, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes. Clin Pharmacol Ther. 2019;105(5):1095–1105. .
   PubMed Web of Science ®Google Scholar
• Matsuoka K. NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease. Intest Res. 2020;18(3):275–281.
   PubMed Web of Science ®Google Scholar
• Van Egmond R, Chin P, Zhang M, et al. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment. Aliment Pharmacol Ther. 2012;35(10):1181–1189.
   PubMed Web of Science ®Google Scholar
• Moradveisi B, Muwakkit S, Zamani F, et al. ITPA, TPMT, and NUDT15 genetic polymorphisms predict 6-mercaptopurine toxicity in Middle Eastern children with acute lymphoblastic leukemia. Front Pharmacol. 2019;10. DOI:10.3389/fphar.2019.00916
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;21(339):b2535. .
   Google Scholar
• Gene Cards Database TPMT Gene. GCID: GC06M018072. http://Genecards.org
   Google Scholar
• Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics. 2004;14(7):407–417.
   PubMedGoogle Scholar
• Fan X, Yin D, Men R, et al. NUDT15 polymorphism confer increased susceptibility to thiopurine-induced leukopenia in patients with autoimmune hepatitis and related cirrhosis. Front Pharmacol. 2019;10:346.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/ (2019).
   Google Scholar
• Munn Z, Moola S, Riitano D, et al. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123–128.
   PubMedGoogle Scholar
• Banerjee R, Ravikanth VV, Pal P, et al. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leukopenia: prospective analysis of 1014 inflammatory bowel disease patients in India. Aliment Pharmacol Ther. 2020;52(11–12):1683–1694.
   PubMed Web of Science ®Google Scholar
• Davavala SK, Desai DC, Abraham P, et al. Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance. Indian J Gastroenterol. 2014;33(1):41–45.
   PubMedGoogle Scholar
• Desire S, Balasubramanian P, Bajel A, et al. Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine. Med Oncol. 2010;27(4):1046–1049.
   PubMed Web of Science ®Google Scholar
• Dorababu P, Nagesh N, Linga VG, et al. Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia. Eur J Clin Pharmacol. 2012;68(4):379–387.
   PubMed Web of Science ®Google Scholar
• Dhawan A, Ruwali M, Pant MC, et al. Association of genetic variability in enzymes metabolizing chemotherapeutic agents with treatment response in head and neck cancer cases. Asia Pac J Clin Oncol. 2017;13(2):e11–e20.
   PubMed Web of Science ®Google Scholar
• Ambar G, Vandana A, Lalit D, et al. Thiopurine S-methyltransferase (TPMT) mutation prevalence and myelosuppression frequency in North Indian patients with autoimmune disorders. J Assoc Physicians India. 2018;66(5):39–44.
   PubMedGoogle Scholar
• Grover N, Bhatia P, Kumar A, et al. Genetic polymorphisms in prediction of thiopurine related cytopenia in inflammatory bowel disease: a prospective study. Abstracts ISGCON 2020
   Google Scholar
• Ilangeswaran S, Mohanan E, Nisham PN, et al. NUDT15 c.415C>T variant explains 6-MP toxicity in patients with acute lymphoblastic leukemia. Indian J Hematol Blood Transfus. 2016;32(Suppl 2):S373–S492.
   Google Scholar
• Iyer SN, Tilak AV, Mukherjee MS, et al. Genotype frequencies of drug-metabolizing enzymes responsible for purine and pyrimidine antagonists in a healthy Asian-Indian population. Biochem Genet. 2012;50(9–10):684–693.
   PubMed Web of Science ®Google Scholar
• Kapoor G, Maitra A, Somlata. Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism. Indian J Med Res. 2009;129(5):500–505.
   PubMed Web of Science ®Google Scholar
• Kapoor G, Sinha R, Naithani R, et al. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia. Leuk Res. 2010;34(8):1023–1026.
   PubMed Web of Science ®Google Scholar
• Kham SK, Tan PL, Tay AH, et al. Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2002;24(5):353–359.
   PubMed Web of Science ®Google Scholar
• Kham SK, Soh CK, Liu TC, et al. Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol. 2008;64(4):373–379.
   PubMed Web of Science ®Google Scholar
• Khera S, Trehan A, Bhatia P, et al. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2019;83(2):341–348.
   PubMed Web of Science ®Google Scholar
• Kodidela S, Dorababu P, Thakkar DN, et al. Association of NUDT15*3 and FPGS2572C>T variants with the risk of early hematologic toxicity during 6-mp and low-dose methotrexate-based maintenance therapy in Indian patients with acute lymphoblastic leukemia. Genes (Basel). 2020;11(6):594.
   Web of Science ®Google Scholar
• Linga VG, Patchva DB, Mallavarapu KM, et al. Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia. Indian J Med Paediatr Oncol. 2014;35(4):276–280.
   PubMedGoogle Scholar
• Murugesan R, Vahab SA, Patra S, et al. Thiopurine S-methyltransferase alleles, TPMT(*)2, (*)3B and (*)3C, and genotype frequencies in an Indian population. Exp Ther Med. 2010;1(1):121–127.
   PubMed Web of Science ®Google Scholar
• Naushad SM, Janaki Ramaiah M, Kutala VK, et al. Pharmacogenetic determinants of thiopurines in an Indian cohort. Pharmacol Rep. 2021;73(1):278–287.
   PubMed Web of Science ®Google Scholar
• Patil S, Ravi Shankar B. Prevalence of TPMT gene polymorphisms in inflammatory bowel disease patients. Indian J Gastroenterol. 2013;32(Suppl 1):A1–A132.
   Google Scholar
• Rashid MMU, Ahmed I, Islam MA, et al. Influence of TPMT polymorphisms on azathioprine-induced myelosuppression in Bangladeshi patients with systemic lupus erythematosus. Drugs Ther Perspect. 2020;36(5):202–207. .
   Google Scholar
• Sadik AM, Siva Prasad S, Guru Prasad M, et al. Thiopurine methyltransferase as a therapeutic indicator of purine analogues: a preliminary study in Southern metropolis. Int J Bioassays. 2013;02:1375–1379.
   Google Scholar
• Sasidharan S, James E, Sudhindran S. Pre-screening tpmt status of liver transplant patients for azathioprine therapy–a single centre experience from south india. Int J Pharm Pharm Sci. 2017;9(2):84–88.
   Google Scholar
• Shah SAV, Paradkar MU, Desai DC, et al. Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity. Drug Metab Pers Ther. 2018;33(1):57–60.
   PubMedGoogle Scholar
• Srinivasan A, Scott JX. Determination of thiopurine methyltransferase (TPMT) status in children with acute lymphoblastic leukemia to customize thiopurine dosage. Pediatr Blood Cancer. 2016;63:S5–S6.
   Web of Science ®Google Scholar
• Umamaheswaran G, Krishna Kumar D, Kayathiri D, et al. Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population. Mol Biol Rep. 2012;39(5):6343–6351.
   PubMed Web of Science ®Google Scholar
• Zaman S, Fukushima H, Suzuki R, et al. TPMT and ITPA gene polymorphism and their adverse events during chemotherapy of acute lymphoblastic leukemia among Bangladeshi children. Iran J Blood Cancer. 2019;11(3):96–100.
   Google Scholar
• Ahmad S, Seshadri M. Genetic polymorphism of six DNA loci in six population groups of India. Hum Biol. 2007;79(4):427–443.
   PubMed Web of Science ®Google Scholar
• Ashavaid TF, Raghavan R, Shah S, et al. TPMT and DPD polymorphisms: efficient screening method for Indian patients considering taking thiopurine and 5-FU drugs. Dis Markers. 2009;27(5):231–238.
   PubMed Web of Science ®Google Scholar
• Dorababu P, Naushad SM, Linga VG, et al. Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL. Pharmacogenomics. 2012;13(9):1001–1008.
   PubMed Web of Science ®Google Scholar
• Kapoor G, Sinha R, Jain S, et al. Methylenetetrahydrofolate reductase (MTHFR) and thiopurine methyltransferase (TPMT) gene polymorphisms and therapy response in indian children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;Supplement Page 849 (abstract).
   Web of Science ®Google Scholar
• Naushad SM, Dorababu P, Rupasree Y, et al. Classification and regression tree-based prediction of 6-mercaptopurine-induced leukopenia grades in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2019;83(5):875–880.
   PubMed Web of Science ®Google Scholar
• Shah SA, Paradkar M, Desai D, et al. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients. J Gastroenterol Hepatol. 2017;32(3):620–624.
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Xavier Scott J. Study to determine the thiopurine methyltransferase (TPMT) status in children with acute lymphoblastic leukemia to customize thiopurine dosage. J clin oncol. 2015;33(15_suppl):e21005–e21005.
   Web of Science ®Google Scholar
• Prabha R, Mathew SK, Joseph AJ, et al. Determination of thiopurine S-methyltransferase activity using reverse-phase high-performance liquid chromatography assay with ultraviolet detection: reference values for the Indian population. J Pharmacol Pharmacother. 2019;10(3):105.
   Web of Science ®Google Scholar
• Moriyama T, Nishii R, Perez-Andreu V, et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet. 2016;48(4):367–373.
   PubMed Web of Science ®Google Scholar
• Broekman MMTJ, Coenen MJH, Wanten GJ, et al. Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype. Aliment Pharmacol Ther. 2017;46(10):953–963.
   PubMed Web of Science ®Google Scholar
• Weinshilboum RM, Sladek S. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methylatransferase activity. Am J Hum Genet. 1980;32(5):651–662.
   PubMed Web of Science ®Google Scholar
• Krynetski EY, Schuetz JD, Galpin AJ, et al. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci USA. 1995;92:949–953.
   PubMed Web of Science ®Google Scholar
• Tai HL, Krynetski EY, Yates CR, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet. 1996;58(4):694–702.
   PubMed Web of Science ®Google Scholar
• Szumlanski C, Otterness D, Her C, et al. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol. 1996;15:17–30.
   PubMed Web of Science ®Google Scholar
• Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at thethiopurine S-methyltransferase gene locus. J Natl Cancer Inst. 1999;91(23). DOI:10.1093/jnci/91.23.2001.
   PubMedGoogle Scholar
• Lennard L. Implementation of TPMT testing. Br J Clin Pharmacol. 2014;77(4):704–714.
   PubMed Web of Science ®Google Scholar
• Sanderson J, Ansari A, Marinaki T, et al. Thiopurine methyltransferase: shouldit be measured before commencing thiopurine drug therapy? Ann Clin Biochem. 2004;41(4):294–302.
   PubMedGoogle Scholar
• Lennard L, Lilleyman JS. Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism. Ther Drug Monit. 1996;18(4):328–334.
   PubMed Web of Science ®Google Scholar
• Lennard L, Lilleyman JS, Van Loon J, et al. Genetic variation inresponse to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet. 1990;336(8709):225–229.
   PubMed Web of Science ®Google Scholar
• Yang SK, Hong M, Baek Choi JH, et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet. 2014;46(9):1017–1020.
   PubMed Web of Science ®Google Scholar
• Yin D, Xia X, Zhang J, et al. Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose. Oncotarget. 2017;8(8):13575–13585.
   PubMedGoogle Scholar
• Wang R, Liu B, Li J, et al. Association between the c.415C > T, c.52G > A, and 36_37insGGAGTC polymorphisms of NUDT 15 and thiopurine-induced leukopenia, thiopurine intolerance, and severe hair loss: an updated meta-analysis. Drug Des Devel Ther. 2019;13:2729–2744.
   PubMed Web of Science ®Google Scholar
• Zhang AL, Yang J, Wang H, et al. Association of NUDT15 c.415C>T allele and thiopurine-induced leukocytopenia in Asians: a systematic review and meta-analysis. Ir J Med Sci. 2018;187(1):145–153.
   PubMed Web of Science ®Google Scholar